AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Metabolic and Immunologic Biomarkers in Chronic Rhinosinusitis With Nasal Polyps

Recruitingn/aAges 18 Years - anyAllHarran University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a heterogeneous inflammatory disease of the sinonasal mucosa whose metabolic and immunologic mechanisms are incompletely understood. This prospective case-control study aims to characterize metabolic and immunologic biomarkers in patients with CRSwNP compared with control subjects. Nasal tissue and peripheral blood samples will be analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) for free amino acid and carnitine/acylcarnitine profiles, and levels of interleukin-40 (IL-40), interleukin-6 (IL-6), and hypoxia-inducible factor-1 alpha (HIF-1ฮฑ) will be measured by ELISA. The findings are expected to contribute to understanding disease pathogenesis and to identifying potential diagnostic biomarkers and therapeutic targets.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
CRSwNP Group Inclusion Criteria: * Age 18 years or older * Diagnosis of chronic rhinosinusitis with nasal polyps at the Otorhinolaryngology outpatient clinic * Diagnosis of nasal polyposis confirmed by histopathological examination of a punch biopsy or surgical specimen * No condition preventing the collection of tissue and peripheral blood samples within the scope of the study Exclusion Criteria: * Acute upper respiratory tract infection or acute rhinosinusitis * History of systemic inflammatory or autoimmune disease * History of malignancy or active malignant disease * Immunodeficiency or use of immunosuppressive therapy * Use of systemic corticosteroids, biologic agents or immunomodulatory therapy within the last 4 weeks * Use of antibiotics for an acute infection within the last 4 weeks * Pregnancy or breastfeeding * Presence of an additional systemic disease severe enough to prevent participation in the study Control Group Inclusion Criteria: * Age 18 years or older * No history of nasal polyposis or chronic rhinosinusitis * Scheduled for septoplasty, rhinoplasty or similar nasal surgery for reasons other than nasal polyps * Collection of a healthy nasal mucosa biopsy during surgery poses no additional risk Exclusion Criteria: \* Same exclusion criteria as the CRSwNP group
๐Ÿ’Š

What it tests

  • Nasal polyp tissue and blood sampling
  • Nasal mucosa and blood sampling
๐Ÿ“

Where

1 site
Harran University Faculty of Medicine Hospital, Department of Otorhinolaryngology
Sanliurfa, Turkey (Tรผrkiye)
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy